Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteriaGeoff D.E. Cuvelier, Kirk R. Schultz, David Mitchell et al.|Blood|2019Cited by 89
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studiesKirk R. Schultz, Geoff D.E. Cuvelier, Amina Kariminia et al.|Blood|2020Cited by 67
NK Cell Tolerance of Self-Specific Activating Receptor KIR2DS1 in Individuals with Cognate HLA-C2 LigandGianfranco Pittari, Bo Dupont, Xiaorong Liu et al.|The Journal of Immunology|2013Cited by 63
Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host diseaseDivya Subburaj, Kirk R. Schultz, Bernard Ng et al.|Blood|2021Cited by 26
A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 studyGeoff D.E. Cuvelier, Kirk R. Schultz, Bernard Ng et al.|Blood Advances|2022Cited by 26